Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
Thumbnail

Fan dies after heart attack at World Cup

A Brazilian soccer fan died after experiencing an MI at the close of a dramatic World Cup match between Brazil and Chile that allowed Brazil to advance to the quarter finals.

Thumbnail

Valve Volumes: Growing Demand, But There’s a Catch

The number of transcatheter aortic valve replacement (TAVR) procedures in the U.S. has been growing with FDA approval of two devices and ongoing clinical trials evaluating other new technologies.

Thumbnail

Getting to the Heart of Heart Failure Management

Managing heart failure (HF) presents daily challenges for many patients. Reasons range from a lack of understanding about treatments to the inability to care for themselves due to symptoms.

Thumbnail

Opportunity Knocks: Starting a Peripheral Artery Disease Program

One decision some cardiology groups may wrangle with is whether or not to launch a peripheral artery disease (PAD) program. 

Early post-op visits to PCP reduce 30-day readmissions

Patients who underwent thoracic aortic aneurysm surgery and experienced complications benefited most from early primary care provider (PCP) visits, according to a study published online June 25 in JAMA: Surgery. Patients who saw their PCP soon after a complicated surgery had a 47 percent decrease in the likelihood of 30-day readmissions compared with those who didn’t.

Recall targets guidewires used in vascular procedures

Nitinol Devices & Components is recalling guidewires after reports of problems during vascular procedures.

Boehringer Ingelheim’s investigational antidote for Pradaxa (dabigatran etexilate mesylate) receives FDA breakthrough therapy designation

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to idarucizumab, an investigational fully humanized antibody fragment, or Fab, being studied as a specific antidote for Pradaxa (dabigatran etexilate mesylate).

Left radial PCI reduces operators’ radiation exposure by half

Radiation exposure to the operator was nearly half when performing PCI by a left radial approach rather than right, according to a study published online June 18 in the Journal of the American College of Cardiology: Cardiovascular Interventions. 

Displaying 7369 - 7376 of 10742

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.